O'Brien; Christopher F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for O'Brien; Christopher F..The latest application filed is for "treatment of hyperkinetic movement disorders".

Company Profile

26.10.24

O'Brien; Christopher F. - San Diego CA
O'Brien; Christopher F. - Vashon WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for the administration of certain VMAT2 inhibitors Grant 11,439,629 - O'Brien , et al. September 13, 2	2022-09-13
High dosage valbenazine formulation and compositions, methods, and kits related thereto Grant 11,311,532 - Moore, Jr. , et al. April 26, 2	2022-04-26
Treatment Of Hyperkinetic Movement Disorders App 20210196702 - O'Brien; Christopher F. ; et al.	2021-07-01
Methods for the administration of certain VMAT2 inhibitors Grant 11,040,029 - O'Brien , et al. June 22, 2	2021-06-22
Methods for the Administration of Certain VMAT2 Inhibitors App 20210169862 - O`Brien; Christopher F. ; et al.	2021-06-10
Methods for the administration of certain VMAT2 inhibitors Grant 11,026,931 - Liang , et al. June 8, 2	2021-06-08
Methods for the administration of certain VMAT2 inhibitors Grant 10,993,941 - O'Brien , et al. May 4, 2	2021-05-04
Use of Valbenazine for Treating Schizophrenia or Schizoaffective Disorder App 20210113553 - O`Brien; Christopher F. ; et al.	2021-04-22
Methods for the administration of certain VMAT2 inhibitors Grant 10,952,997 - O'Brien , et al. March 23, 2	2021-03-23
Methods for the Administration of Certain VMAT2 Inhibitors App 20210046060 - O`Brien; Christopher F. ; et al.	2021-02-18
Methods for the Administration of Certain VMAT2 Inhibitors App 20210038593 - O`Brien; Christopher F. ; et al.	2021-02-11
Methods for the administration of certain VMAT2 inhibitors Grant 10,912,771 - O'Brien , et al. February 9, 2	2021-02-09
High Dosage Valbenazine Formulation and Compositions, Methods, and Kits Related Thereto App 20210030743 - Moore, JR.; Richard Alexander ; et al.	2021-02-04
High Dosage Valbenazine Formulation and Compositions, Methods, and Kits Related Thereto App 20210030744 - Moore, JR.; Richard Alexander ; et al.	2021-02-04
Methods for the Administration of Certain VMAT2 Inhibitors App 20210030742 - O'Brien; Christopher F. ; et al.	2021-02-04
Methods for the administration of certain VMAT2 inhibitors Grant 10,874,648 - O'Brien , et al. December 29, 2	2020-12-29
Methods for the administration of certain VMAT2 inhibitors Grant 10,857,148 - O'Brien , et al. December 8, 2	2020-12-08
Methods for the administration of certain VMAT2 inhibitors Grant 10,857,137 - O'Brien , et al. December 8, 2	2020-12-08
Methods For The Administration Of Certain Vmat2 Inhibitors App 20200360354 - Liang; Grace S. ; et al.	2020-11-19
Methods for the Administration of Certain VMAT2 Inhibitors App 20200338066 - O`Brien; Christopher F. ; et al.	2020-10-29
High Dosage Valbenazine Formulation and Compositions, Methods, and Kits Related Thereto App 20200276184 - Moore, Jr.; Richard Alexander ; et al.	2020-09-03
Methods for the Administration of Certain VMAT2 Inhibitors App 20200268743 - O`Brien; Christopher F. ; et al.	2020-08-27
Methods for the Administration of Certain VMAT2 Inhibitors App 20200268724 - O`Brien; Christopher F. ; et al.	2020-08-27
Methods for the Administration of Certain VMAT2 Inhibitors App 20200268725 - O`Brien; Christopher F. ; et al.	2020-08-27
Methods for the Administration of Certain VMAT2 Inhibitors App 20200268744 - O`Brien; Christopher F. ; et al.	2020-08-27
Methods for the Administration of Certain VMAT2 Inhibitors App 20200268745 - O`Brien; Christopher F. ; et al.	2020-08-27
Methods for the Administration of Certain VMAT2 Inhibitors App 20200230127 - O`Brien; Christopher F. ; et al.	2020-07-23
Use Of Valbenazine For Treating Levodopa-induced Dyskinesia App 20200179352 - O`Brien; Christopher F.	2020-06-11
Treatment Of Hyperkinetic Movement Disorders App 20200101063 - O'Brien; Christopher F. ; et al.	2020-04-02
Methods for the Administration of Certain VMAT2 Inhibitors App 20200093808 - O`Brien; Christopher F. ; et al.	2020-03-26
Use of Valbenazine for Treating Schizophrenia or Schizoaffective Disorder App 20200078352 - O`Brien; Christopher F.	2020-03-12
Methods for the Administration of Certain VMAT2 Inhibitors App 20190381016 - O`Brien; Christopher F. ; et al.	2019-12-19
Vmat2 Inhibitors For Treating Neurological Diseases Or Disorders App 20190015396 - O'BRIEN; Christopher F.	2019-01-17
Treatment Of Hyperkinetic Movement Disorders App 20170071932 - O'Brien; Christopher F.	2017-03-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.